Biotech

All Articles

Former Seagen CEO unveils brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer in 2014 for an en...

Ironwood makes further purpose $1B GI medicine with brand new subgroup records

.On the heels of a period 3 win that failed to impress investors, Ironwood Pharmaceuticals is actual...

Novartis inks $150M bargain for autoimmune molecular glue

.Don't cease Monte Rosa Therapeutics currently. The Boston-based biotech is enjoying after authorizi...

Jade takes officer staff with Chinook vets-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings ...

Septerna goes public along with upsized offering of $288M

.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the openin...

AbbVie brings in Richter wealthier, paying for $25M to form breakthrough deal

.AbbVie has actually come back to the resource of its own antipsychotic powerhouse Vraylar trying to...

GenSight enters last full weeks of cash money path as earnings stream noses out of scope

.GenSight Biologics is actually full weeks off of losing cash. Once again. The biotech simply posses...

AZ licenses discarded uncommon illness medicine to Monopar Rehabs

.Monopar Therapeutics is actually bouncing back a medication coming from the scrap heap of AstraZene...

Arcus' new HIF-2a records in renal cancer mean possible upper hand over Merck's Welireg, analysts point out

.Along with brand-new records out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ...

Roche wagers approximately $1B to grow Dyno gene treatment shipment contract

.After forming a gene therapy relationship with Dyno Therapies in 2020, Roche is back for more.In a ...